PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1454094
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1454094
Blue Biotechnology Market size was valued at USD 2,345 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.
Blue biotechnology refers to the application of biological techniques and technology on aquatic organisms in order to acquire knowledge or gain advantages. It encompasses a wide range of applications on humans, animals, and the environment. By studying various marine species, blue biotechnology aims to identify potential uses for them in the creation of novel products, including chemicals, food items, wellness products like food supplements and cosmetics, pharmaceuticals, and energy sources. This field involves the utilization of marine organisms to extract specific molecules and oils. The blue economy greatly benefits from blue biotechnology as it allows for the sustainable exploitation and preservation of the marine biotech industry and ecosystem.
Blue Biotechnology Market- Market Dynamics
Rising Awareness regarding the use of synthetic medicines is expected to dominate the growth of market.
The growing recognition of the potential of marine biotechnology in the field of drug discovery and development has the potential to attract increased investment and research in this area. Medicines synthesized from marine sources have the ability to provide unique drug candidates with a wide range of pharmacological activities, such as anti-inflammatory, anti-cancer, antimicrobial, and neuroprotective properties. This could stimulate innovation and the creation of new drugs that target unmet medical needs. According to the Food and Drug Administration (FDA), there are over 200 identified synthetic drug compounds and more than 90 different synthetic drug marijuana compounds. Additionally, advancements in biotechnological techniques and the field of drug discovery and development offer promising growth opportunities for the market. However, it is important to consider environmental concerns that may potentially limit the growth of this market.
Blue Biotechnology Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
Based on Product segmentation, Enzymes was predicted to show maximum market share in the year 2023
Based on application segmentation, Vaccine Development was the leading type in 2023
Based on End-User segmentation, Pharmaceutical Companies was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Blue Biotechnology Market is segmented on the basis of Product, Application, End-User, and Region.
The market is categorized into three groups according to the product: Enzymes, Pharma Products, Bulk Chemicals, Biopolymers, and Others. Enzymes hold a dominant position in the market. Within the Blue Biotechnology sector, marine-derived enzymes are widely utilized in various industries including biofuel production, pulp and paper manufacturing, textile processing, and wastewater treatment.
The market is segmented into two categories according to application: Bioengineering, Genomics, Vaccine Development, Drug Discovery, and Other. Vaccine Development is the leading sector in the market. Biotechnology research is concentrated on creating innovative formulation techniques to enhance the stability and longevity of vaccines, which is especially crucial for vaccines distributed in areas with limited resources or during global health crises.
The market is segmented into five categories according to their End-user: Hospitals, Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Laboratories, and Others. Pharmaceutical Companies lead the market. These companies have the opportunity to investigate marine biodiversity by engaging in bio prospecting activities in order to uncover new drug candidates for different therapeutic purposes.
Blue Biotechnology Market- Geographical Insights
Geographically, this market extends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved. The market in North America is dominant, primarily due to the increasing demand for natural products. This demand for natural products is a global phenomenon driven by consumer preferences for healthier and environmentally friendly alternatives. While North America holds a significant share in the market for natural products, other regions also demonstrate strong demand. In the United States alone, sales of natural and organic products witnessed an estimated growth of 7.7% to reach USD272 billion in 2021. It is projected that these sales will exceed USD300 billion by 2024 and USD400 billion by 2030, as reported by New Hope Network's State of Natural and Organic. Europe and Asia Pacific are the second-largest regions contributing to the market's growth, owing to their distinct marine ecosystems, species, and biochemical diversity.
In the competitive landscape of the Blue Biotechnology market, companies are engaged in the discovery and development of innovative marine-derived compounds for various applications such as therapeutics, nutrition, and industry. Research and development (R&D) investments play a vital role in maintaining a competitive edge in this sector. Companies aim to set themselves apart by concentrating on specific therapeutic areas or applications like pharmaceuticals, nutraceuticals, cosmeceuticals, or biofuels. Competition in the Blue Biotechnology market transcends national boundaries, as companies strive to broaden their global footprint. This entails forming partnerships, securing distribution agreements, and entering into licensing arrangements to reach new markets and customers.
In August 2021, New England Biolabs unveiled its latest offerings in loop-mediated isothermal amplification (LAMP) products. These include the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG). What sets these products apart is that they combine the master mix and LAMP fluorescent dye into a single, user-friendly kit. With these new additions, researchers now have the capability to swiftly and efficiently detect specific segments of DNA or RNA through various amplification detection methods.
GLOBAL BLUE BIOTECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Aker BioMarine
Marinova
New England Biolabs
PML Applications Ltd.
Sea Run Holdings, Inc.
PICES
Donald Danforth Plant Science Center
Shell Marine Products
GeoMarine Biotechnologies
GlycoMar
Cellgen Biologicals Pvt Ltd.
Nurture Aqua Technology Pvt. Ltd.
Samudra Biopharma Pvt. Ltd
Sanosil Biotech
Others